Mupirocin
Sold as Banderm nasal, Banderm topical, Bactroban, Supiroban, Banogon, Nuban, Dermoban, Mupirocin glenmark, Muprican, Piban, Bactroban topical, Bactroban nasal
No structure available
This product's active ingredient could not be matched to a single known compound.
Background
Registration
- Applicants
- 8
- Registrations
- 12
- Schedule source
- SAHPRA documentation
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Viatris South Africa (Pty) Ltd | Banderm nasal, Banderm topical | Not stated | 290536, 290537 | Not determined | None |
| Glaxosmithkline South Africa (Pty) LimitedCertificate held by Glaxosmithkline South Africa (Pty) Ltd | Bactroban, Bactroban topical, Bactroban nasal | cream, 2 g, 20mg | 340274, T0075, W0218 | S2 | PIPIL |
| Glenmark Pharmaceuticals South Africa (Pty) Ltd | Supiroban, Mupirocin glenmark | ointment | 430680, 470728 | Not determined | None |
| Pharmacare limited û woodmead | Banogon | ointment | 431139 | Not determined | None |
| Pharma Dynamics (Pty) LtdCancelled | Nuban | ointment | 440971 | Not determined | None |
| Unicorn Pharmaceuticals (Pty) Ltd | Dermoban | 20 mg | 440972 | Not determined | PIPIL |
| Abex Pharmaceutica (Pty) Ltd | Muprican | 20 mg | 520254 | S2 | PIPIL |
| Macleods Pharmaceuticals SA (Pty) LtdCertificate held by Abex Pharmaceutica (Pty) Ltd | Piban | 20 mg | 520255.254 | S2 | PIPIL |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Banderm nasal 100 G MUPIROCIN CALCIUM 2,15 G | Not listed | 29053629/20.1.6/0536 | Registered | Not determined | None |
| Banderm topical 100G MUPIROCIN 2 G | Not listed | 29053729/20.1.6/0537 | Registered | Not determined | None |
| Bactroban cream EACH 100,0 g CREAM CONTAINS MUPIROCIN CALCIUM EQUIVALENT TO MUPIROCIN 2,0 g | Cream | 34027434/20.1.6/0274 | Registered | Not determined | None |
| Supiroban EACH 1,0 g OINTMENT CONTAINS MUPIROCIN 20,0 mg | Not listed | 43068043/20.1.6/0680 | Registered | Not determined | None |
| Banogon ointment EACH 1,0 g OINTMENT CONTAINS MUPIROCIN 2,0 mg | Ointment | 43113943/20.1.6/1139 | Registered | Not determined | None |
| Nuban ointment EACH 1,0 g OINTMENT CONTAINS MUPIROCIN 20,0 mg | Ointment | 44097144/20.1.6/0971 | Cancelled | Not determined | None |
| Dermoban ointment EACH 1,0 g OINTMENT CONTAINS MUPIROCIN 20,0 mg | 20 mgOintments. | 44097244/20.1.6/0972Approved 13 February 2025 | Registered | Not determined | PIPIL |
| Mupirocin ointment glenmark Each 1,0g of ointment contains MUPIROCIN 20,0 mg | Ointment | 47072847/20.1.6/0728 | Registered | Not determined | None |
| Muprican EACH 1,0 g CONTAINS: MUPIROCIN 20,0 mg | 20 mgOintment | 52025452/20.1.6/0254Approved 31 May 2025 | Registered | S2 | PIPIL |
| Piban Each gram contains MUPIROCIN 20,0 mg | 20 mgOintment | 520255.25452/20.1.6/0255.254Approved 30 June 2023 | Registered | S2 | PIPIL |
| Bactroban topical EACG 100,0 g OINTMENT CONTAINS MUPIROCIN 2,0 g | 20mgOintment | T0075T/20.1.6/0075Approved 3 March 2016 | Registered | S2 | PIPIL |
| Bactroban nasal EACH 100 g OINTMENT CONTAINS MUPIROCIN 2 g | 2 gOintment | W0218W/20.1.6/218Approved 3 March 2016 | Registered | S2 | PIPIL |
Regulatory status
Where S2 sits on the scale
A pharmacist can sell it directly, without a prescription.
Schedule 2 medicines sit behind the pharmacy counter. A pharmacist can decide to sell one of these directly, using their own professional judgement, without a doctor's prescription. It can also be dispensed against a prescription like the higher tiers, in which case the usual repeat limits apply. A child under 12 may only be sold a Schedule 2 substance on a prescription, or on a written order that names the purpose and carries a signature the seller recognises. Even though it cannot be advertised to the public in the ordinary sense, its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S2, read from the product's PI-PIL leaflet.
The Consolidated Schedules list this ingredient up to S4; the leaflet's S2 applies to this product.
Who may supply: Only a pharmacist, pharmacist intern or supervised pharmacist's assistant may sell it without a prescription. It may otherwise be dispensed by a pharmacist against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Mupirocin
S4: Mupirocin
- except when intended for topical application to the epidermis, nares and external ear.
Consolidated Schedules 06 July 2026, line 7193
S2: Mupirocin
- when intended for application to the skin, nares and external ear.
Consolidated Schedules 06 July 2026, line 2359
Pharmacological class: Topical antibiotics. (class 20.1.6)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.